ORIENT BIO Inc. (KRX: 002630)
South Korea
· Delayed Price · Currency is KRW 459.00
-1.00 (-0.22%)
Oct 10, 2024, 3:30 PM KST
ORIENT BIO Ratios and Metrics
Market cap in millions KRW. Fiscal year is April - March.
Millions KRW. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2016 - 2012 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 9, 2024 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | 2016 - 2012 |
| Market Capitalization | 54,541 | 187,317 | 58,433 | 107,869 | 176,914 | 194,884 | Upgrade
|
| Market Cap Growth | -3.55% | 220.57% | -45.83% | -39.03% | -9.22% | -14.92% | Upgrade
|
| Enterprise Value | 146,781 | 190,173 | 60,013 | 198,892 | 236,940 | 251,125 | Upgrade
|
| Last Close Price | 460.00 | 1580.00 | 574.00 | 1059.72 | 2347.29 | 2617.72 | Upgrade
|
| PE Ratio | - | -11.44 | -4.94 | -4.21 | -12.16 | -9.40 | Upgrade
|
| PS Ratio | 0.92 | 3.60 | 1.57 | 3.55 | 6.90 | 1.79 | Upgrade
|
| PB Ratio | 1.03 | 3.86 | 1.11 | 1.72 | 2.21 | 2.14 | Upgrade
|
| P/FCF Ratio | 5.85 | 22.08 | -12.57 | -3.91 | -35.72 | -18.75 | Upgrade
|
| P/OCF Ratio | 12.32 | 21.43 | -14.97 | -9.35 | -89.97 | -38.15 | Upgrade
|
| EV/Sales Ratio | 2.48 | 3.66 | 1.61 | 6.55 | 9.25 | 2.30 | Upgrade
|
| EV/EBITDA Ratio | 109.61 | 649.60 | -5.86 | -116.07 | -383.39 | -80.62 | Upgrade
|
| EV/EBIT Ratio | -51.13 | -43.24 | -3.96 | -20.31 | -29.94 | -25.68 | Upgrade
|
| EV/FCF Ratio | 15.73 | 22.42 | -12.91 | -7.20 | -47.84 | -24.17 | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.17 | 0.18 | 0.13 | 0.80 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | 7.96 | 27.69 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | 1.14 | 0.96 | -2.06 | -0.30 | -12.95 | -4.98 | Upgrade
|
| Asset Turnover | 0.72 | 0.71 | 0.47 | 0.22 | 0.14 | 0.64 | Upgrade
|
| Inventory Turnover | 5.30 | 4.74 | 3.42 | 1.35 | 0.78 | 3.30 | Upgrade
|
| Quick Ratio | 1.11 | 1.32 | 0.98 | 1.14 | 0.63 | 0.70 | Upgrade
|
| Current Ratio | 1.80 | 1.91 | 1.75 | 2.17 | 1.06 | 1.36 | Upgrade
|
| Return on Equity (ROE) | -12.42% | -30.93% | -22.15% | -18.49% | -15.34% | -27.72% | Upgrade
|
| Return on Assets (ROA) | -2.20% | -3.73% | -11.84% | -4.46% | -2.78% | -3.58% | Upgrade
|
| Return on Capital (ROIC) | -2.75% | -4.63% | -14.24% | -5.69% | -3.45% | -4.18% | Upgrade
|
| Earnings Yield | -12.57% | -8.35% | -20.53% | -18.08% | -7.84% | -10.05% | Upgrade
|
| FCF Yield | 17.11% | 4.53% | -7.95% | -25.61% | -2.80% | -5.33% | Upgrade
|
| Buyback Yield / Dilution | -8.36% | -9.70% | -32.48% | -8.49% | -2.09% | -10.20% | Upgrade
|
| Total Shareholder Return | -8.36% | -9.70% | -32.48% | -8.49% | -2.09% | -10.20% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.